Wolfe Research initiated coverage of Pfizer (PFE) with an Underperform rating and $25 price target
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Notable open interest changes for November 13th
- Pfizer Considers Selling Hospital Unit to Free Up Cash and Reduce Debt
- NVAX Earnings: Novavax Stock Down on Weak 2024 Revenue Outlook
- Elliott confirms big Honeywell stake, Home Deport reports Q3 beat: Morning Buzz
- Pfizer said to be exploring sale of hospital drugs unit, Reuters reports